Skip to content
Subscriber Only
Business
Prognosis

WHO to Restart Hydroxychloroquine Trial as Risks Questioned

Video player cover image
Watch: WHO chief Tedros says an international trial using hydroxychloroquine to treat Covid-19 patients will be restarted.(Source: WHO/Bloomberg)
Updated on

An international trial using hydroxychloroquine to treat Covid-19 patients will be restarted after questions arose about a study linking the antimalarial drug to increased death and heart risks.

The World Health Organization said Wednesday that it will resume recruiting patients for the hydroxychloroquine arm of a global trial called Solidarity. The agency had paused the branch of the experiment, which compares the impact of a number of treatment regimens, after the drug was linked to heart risks in research published in the Lancet, a medical journal.